Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Mitoxantrone → Glatiramer Acetate vs Interferon Beta-1a in early active RRMS
2004-004903-39Phase 4Completed
- Sponsor
- The Walton Centre
- Start
- Jun 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in multiple sclerosis (MS) comparing Sequential Mitoxantrone → Copaxone with Interferon Beta-1a (2 arms). Primary endpoint: Multiple Sclerosis Impact Scale (MSIS). Started Jun 2005; status: completed.
02
Drugs
mitoxantroneglatiramer acetateinterferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2004-004903-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004903-39.